Search results for "Anticoagulation"
MKSAP Quiz: diagnosing hematologic abnormalities
This week's quiz asks readers to determine appropriate diagnostic testing for a 26-year-old woman admitted to the hospital with deep venous thrombosis.
https://immattersacp.org/weekly/archives/2011/11/15/3.htm
15 Nov 2011
Self-testing, self-dosage for anticoagulation safe, suitable option for some patients, study indicates
Self-testing and self-dosage of oral anticoagulation may be safe and suitable for patients of all ages with suitable health care support as backup, according to a meta-analysis.
https://immattersacp.org/weekly/archives/2011/12/06/1.htm
6 Dec 2011
Bleeding risk of dabigatran under scrutiny
Serious bleeding events have been reported in patients taking dabigatran (Pradaxa), according to a new FDA MedWatch alert.
https://immattersacp.org/weekly/archives/2011/12/13/7.htm
13 Dec 2011
Drug-eluting stents associated with benefits in patients age 85 and older
Drug-eluting stents are being used less often in elderly patients, even though their use is associated with better outcomes in these patients, a new study found.
https://immattersacp.org/weekly/archives/2012/01/10/4.htm
10 Jan 2012
MKSAP Quiz: acute left-sided flank pain
This week's quiz asks readers to evaluate a 58-year-old woman who is hospitalized for acute left-sided flank pain.
https://immattersacp.org/weekly/archives/2012/01/24/3.htm
24 Jan 2012
Updated guidelines released on antithrombotic therapy, thrombosis prevention
The American College of Chest Physicians released updated guidelines last week on antithrombotic therapy and prevention of thrombosis.
https://immattersacp.org/weekly/archives/2012/02/14/2.htm
14 Feb 2012
Fixed-dose oral rivaroxaban appears noninferior to standard therapy for PE
Fixed-dose oral rivaroxaban is as effective as standard anticoagulant therapy for pulmonary embolism (PE) and may have a lower bleeding risk, a new study found.
https://immattersacp.org/weekly/archives/2012/03/27/5.htm
27 Mar 2012
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012
Decisional conflict: Balancing risks, benefits for each patient
A 73-year-old man struggles with the decision whether to consider anticoagulation for atrial fibrillation, a “decisional conflict” that affects many trying to balance risks and rewards of medical treatments. Doctors should help the patients choose, but then abide by that decision.
https://immattersacp.org/archives/2012/04/gray-matters.htm
1 Apr 2012
No such thing as ‘one fits all’ for physicians and mobile devices
Technological devices can make physicians lives easier, but integrating them can be difficult. Physicians report on how they make the many mobile devices work in their offices.
https://immattersacp.org/archives/2012/04/editors.htm
1 Apr 2012